drugset / Trial / NCT06584474

THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA

NCT06584474

Phase 4 Completed 100 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to determine the effectiveness of nebulized azithromycin therapy in prevention of BPD in very low birth weight preterm infants when compared with placebo.

Timeline

Start
2024-10-02
Primary completion
2025-06-02
Completion
2025-07-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 20 mg/kg Inhaled